Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: The present study aimed to determine the role of cystatin C as a prognostic factor for acute kidney injury and survival in cirrhotic patients. Methods: The study investigated 53 liver cirrhosis patients. The renal function was evaluated by serum creatinine, serum and urine cystatin C, and 24-hour creatinine clearance on admission. Acute kidney injury was defined as a serum creatinine level exceeding the normal range (>1.2 mg/dl) and an increase of at least 50% from the baseline value. Multivariate analysis, receiver operating characteristic curve, and survival analysis were used to investigate prognostic factors for acute kidney injury and survival. Results: Nine of the 53 cirrhotic patients (17.0%) developed acute kidney injury within 3 months. Both serum creatinine and cystatin C were predictive factors for acute kidney injury in univariate analysis, with a diagnostic accuracy of 0.735 (95% confidence interval (CI), 0.525-0.945; p=0.028) for serum cystatin C and 0.698 (95% CI, 0.495-0.901, p=0.063) for creatinine. In multivariate analysis, only serum cystatin C was an independent risk factor for acute kidney injury. The sensitivity and specificity of a serum cystatin C level of >1.23 mg/L to acute kidney injury were 66% and 86%, respectively. Serum cystatin C was positively correlated with the Model for End-Stage Liver Disease (MELD) and MELD-Na scores (r=0.346 and p=0.011, and r=0.427 and p=0.001, respectively). Comparison of the survival rates over the observation period revealed that a serum cystatin C level of >1.23 mg/L was a useful marker for short-term mortality (p<0.001). Conclusions: The accuracy in predicting acute kidney injury and short-term mortality was higher for a serum cystatin C level of >1.23 mg/L than for the serum creatinine concentration in patients with cirrhosis.
Abstract
Background/Aims: The present study aimed to determine the role of cystatin C as a prognostic factor for acute kidney injury and survival in cirrhotic patients. Methods: The study investigated 53 liver cirrhosis patients. The renal function was evaluated by serum creatinine, serum and urine cystatin C, and 24-hour creatinine clearance on admission. Acute kidney injury was defined as a serum creatinine level exceeding the normal range (>1.2 mg/dl) and an increase of at least 50% from the baseline value. Multivariate analysis, receiver operating characteristic curve, and survival analysis were used to investigate prognostic factors for acute kidney injury and survival. Results: Nine of the 53 cirrhotic patients (17.0%) developed acute kidney injury within 3 months. Both serum creatinine and cystatin C were predictive factors for acute kidney injury in univariate analysis, with a diagnostic accuracy of 0.735 (95% confidence interval (CI), 0.525-0.945; p=0.028) for serum cystatin C and 0.698 (95% CI, 0.495-0.901, p=0.063) for creatinine. In multivariate analysis, only serum cystatin C was an independent risk factor for acute kidney injury. The sensitivity and specificity of a serum cystatin C level of >1.23 mg/L to acute kidney injury were 66% and 86%, respectively. Serum cystatin C was positively correlated with the Model for End-Stage Liver Disease (MELD) and MELD-Na scores (r=0.346 and p=0.011, and r=0.427 and p=0.001, respectively). Comparison of the survival rates over the observation period revealed that a serum cystatin C level of >1.23 mg/L was a useful marker for short-term mortality (p<0.001). Conclusions: The accuracy in predicting acute kidney injury and short-term mortality was higher for a serum cystatin C level of >1.23 mg/L than for the serum creatinine concentration in patients with cirrhosis.
참고문헌 (22)
- Arroyo V, "Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club", Hepatology, 23, pp.164~176 (1996)
- Gerbes AL, "Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver", Gut, 50, pp.106~110 (2002)
- Cockcroft DW, "Prediction of creatinine clearance from serum creatinine", Nephron, 16, pp.31~41 (1976)
- Levey AS, "A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group", Ann Intern Med, 130, pp.461~470 (1999)
- Sherman DS, "Assessing renal function in cirrhotic patients: problems and pitfalls", Am J Kidney Dis, 41, pp.269~278 (2003)
- Caregaro L, "Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis", Arch Intern Med, 154, pp.201~205 (1994)
- Ruf AE, "Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone", Liver Transpl, 11, pp.336~343 (2005)
- Mishra J, "Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury", J Am Soc Nephrol, 14, pp.2534~2543 (2003)
- Parikh CR, "Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit", J Am Soc Nephrol, 16, pp.3046~3052 (2005)
- Lopez-Hoyos M, "Association between serum soluble CD30 and serum creatinine before and after renal transplantation", Transplant Proc, 40, pp.2903~2905 (2008)
- Bonventre JV, "Diagnosis of acute kidney injury: from classic parameters to new biomarkers", Contrib Nephrol, 156, pp.213~219 (2007)
- Uchida K, "Measurement of cystatin-C and creatinine in urine", Clin Chim Acta, 323, pp.121~128 (2002)
- Herget-Rosenthal S, "Early detection of acute renal failure by serum cystatin C", Kidney Int, 66, pp.1115~1122 (2004)
- de Boer IH, "Cystatin C, albuminuria, and mortality among older adults with diabetes", Diabetes Care, 32, pp.1833~1838 (2009)
- Ix JH, "Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study", Circulation, 115, pp.173~179 (2007)
- Kim WR, "Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list", N Engl J Med, 359, pp.1018~1026 (2008)
- Hoek FJ, "A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate", Nephrol Dial Transplant, 18, pp.2024~2031 (2003)
- Larsson A, "Calculation of glomerular filtration rate expressed in mL", min from plasma cystatin C values in mg, Scand J Clin Lab Invest, pp.2004, 64[DOI]
- Seo YS, "Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels", Liver Int, 29, pp.1521~1527 (2009)
- Tian S, "Cystatin C measurement and its practical use in patients with various renal diseases", Clin Nephrol, 48, pp.104~108 (1997)
- Hellerstein S, "The ratio of urinary cystatin C to urinary creatinine for detecting decreased GFR", Pediatr Nephrol, 19, pp.521~525 (2004)
- Koyner JL, "Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery", Kidney Int, 74, pp.1059~1069 (2008)